Changes in fatigue of Parkinson’s disease during the recurrent COVID-19 pandemic: Findings from the longitudinal analysis of the PHASE study.

Publication date: Dec 01, 2024

According to Japanese law, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection during the COVID-19 pandemic falls under Category 2, implying that it necessitates hospitalization, isolation, and significant government participation. The category of infection was lowered to Category 5 in May 2023, meaning that individuals were going back to live their lives as they did before the COVID-19 pandemic. This study aimed to explore changes in the prevalence of non-motor symptoms over a longer four-year period, spanning before and after the COVID-19 pandemic. We conducted a questionnaire survey between January and February in the following years: 2021, 2022, 2023, and 2024. The Parkinson’s fatigue scale score in 2021 (mean: 35. 3) increased significantly in 2022 (49. 84), 2023 (49. 33), and 2024 (54. 71) (p

Concepts Keywords
February Aged
Japanese Coronavirus
Pandemic COVID
Parkinsonism COVID-19
Fatigue
Fatigue
Female
Humans
Japan
Longitudinal Studies
Male
Middle Aged
Non-motor symptom
Parkinson Disease
Parkinson’s disease
Surveys and Questionnaires

Semantics

Type Source Name
disease MESH Parkinson’s disease
disease MESH COVID-19 pandemic
disease MESH infection
disease MESH Long Covid
disease IDO symptom
pathway KEGG Parkinson disease

Original Article

(Visited 1 times, 1 visits today)